GO:0034641 | cellular nitrogen compound metabolic process | 27.11% (45/166) | 2.61 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 16.87% (28/166) | 3.25 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 18.67% (31/166) | 2.85 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 19.88% (33/166) | 2.6 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 30.12% (50/166) | 1.85 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 19.88% (33/166) | 2.48 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 19.88% (33/166) | 2.44 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 19.88% (33/166) | 2.41 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 10.24% (17/166) | 3.6 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 16.27% (27/166) | 2.55 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 10.84% (18/166) | 3.41 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 70.48% (117/166) | 0.72 | 0.0 | 0.0 |
GO:0005488 | binding | 53.01% (88/166) | 0.96 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 7.83% (13/166) | 4.01 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 33.13% (55/166) | 1.39 | 0.0 | 0.0 |
GO:0009987 | cellular process | 39.16% (65/166) | 1.22 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 30.72% (51/166) | 1.44 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 22.29% (37/166) | 1.78 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 29.52% (49/166) | 1.41 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 6.02% (10/166) | 4.22 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 11.45% (19/166) | 2.63 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 8.43% (14/166) | 3.22 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 33.73% (56/166) | 1.18 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 11.45% (19/166) | 2.52 | 0.0 | 0.0 |
GO:0043226 | organelle | 12.05% (20/166) | 2.42 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 12.05% (20/166) | 2.42 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 10.24% (17/166) | 2.67 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 8.43% (14/166) | 3.02 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 8.43% (14/166) | 3.02 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 7.83% (13/166) | 3.05 | 0.0 | 0.0 |
GO:0005840 | ribosome | 7.23% (12/166) | 3.18 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 13.25% (22/166) | 2.08 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 33.73% (56/166) | 1.07 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 7.83% (13/166) | 2.9 | 0.0 | 0.0 |
GO:0006412 | translation | 7.23% (12/166) | 3.04 | 0.0 | 1e-06 |
GO:0043043 | peptide biosynthetic process | 7.23% (12/166) | 3.0 | 0.0 | 1e-06 |
GO:0140513 | nuclear protein-containing complex | 6.02% (10/166) | 3.39 | 0.0 | 1e-06 |
GO:1901576 | organic substance biosynthetic process | 13.25% (22/166) | 1.96 | 0.0 | 1e-06 |
GO:0008152 | metabolic process | 34.34% (57/166) | 1.01 | 0.0 | 1e-06 |
GO:0006399 | tRNA metabolic process | 4.82% (8/166) | 3.96 | 0.0 | 1e-06 |
GO:1901566 | organonitrogen compound biosynthetic process | 9.64% (16/166) | 2.39 | 0.0 | 1e-06 |
GO:0043604 | amide biosynthetic process | 7.23% (12/166) | 2.91 | 0.0 | 1e-06 |
GO:0110165 | cellular anatomical entity | 18.07% (30/166) | 1.55 | 0.0 | 1e-06 |
GO:0065003 | protein-containing complex assembly | 4.82% (8/166) | 3.83 | 0.0 | 2e-06 |
GO:0022618 | protein-RNA complex assembly | 3.01% (5/166) | 5.4 | 0.0 | 2e-06 |
GO:0097159 | organic cyclic compound binding | 31.93% (53/166) | 1.02 | 0.0 | 2e-06 |
GO:0009058 | biosynthetic process | 13.25% (22/166) | 1.84 | 0.0 | 3e-06 |
GO:0071826 | protein-RNA complex organization | 3.01% (5/166) | 5.18 | 0.0 | 3e-06 |
GO:0008150 | biological_process | 47.59% (79/166) | 0.72 | 0.0 | 3e-06 |
GO:0005515 | protein binding | 23.49% (39/166) | 1.23 | 0.0 | 4e-06 |
GO:0017056 | structural constituent of nuclear pore | 2.41% (4/166) | 5.99 | 0.0 | 5e-06 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 2.41% (4/166) | 5.74 | 1e-06 | 1e-05 |
GO:0022607 | cellular component assembly | 4.82% (8/166) | 3.4 | 1e-06 | 1.3e-05 |
GO:0003743 | translation initiation factor activity | 3.01% (5/166) | 4.53 | 3e-06 | 3e-05 |
GO:0043933 | protein-containing complex organization | 4.82% (8/166) | 3.2 | 3e-06 | 3.4e-05 |
GO:0009451 | RNA modification | 4.22% (7/166) | 3.5 | 3e-06 | 3.5e-05 |
GO:0006364 | rRNA processing | 3.01% (5/166) | 4.29 | 6e-06 | 6.6e-05 |
GO:0001510 | RNA methylation | 2.41% (4/166) | 4.99 | 8e-06 | 8e-05 |
GO:0008033 | tRNA processing | 3.01% (5/166) | 4.22 | 8e-06 | 8.1e-05 |
GO:0016072 | rRNA metabolic process | 3.01% (5/166) | 4.16 | 9e-06 | 9.7e-05 |
GO:0043414 | macromolecule methylation | 3.01% (5/166) | 4.14 | 1e-05 | 0.000102 |
GO:1990904 | ribonucleoprotein complex | 4.22% (7/166) | 3.21 | 1.2e-05 | 0.000119 |
GO:0000387 | spliceosomal snRNP assembly | 1.81% (3/166) | 5.77 | 2.1e-05 | 0.000207 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 6.02% (10/166) | 2.39 | 2.4e-05 | 0.000235 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 6.02% (10/166) | 2.39 | 2.5e-05 | 0.000239 |
GO:0090079 | translation regulator activity, nucleic acid binding | 3.01% (5/166) | 3.84 | 2.8e-05 | 0.00026 |
GO:0008135 | translation factor activity, RNA binding | 3.01% (5/166) | 3.84 | 2.8e-05 | 0.00026 |
GO:0032259 | methylation | 3.01% (5/166) | 3.79 | 3.3e-05 | 0.000301 |
GO:0045182 | translation regulator activity | 3.01% (5/166) | 3.76 | 3.7e-05 | 0.000329 |
GO:0071840 | cellular component organization or biogenesis | 7.23% (12/166) | 2.04 | 4.1e-05 | 0.000362 |
GO:0032040 | small-subunit processome | 1.81% (3/166) | 5.33 | 5.5e-05 | 0.000482 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 5.42% (9/166) | 2.36 | 7.3e-05 | 0.00063 |
GO:0030684 | preribosome | 1.81% (3/166) | 5.18 | 7.6e-05 | 0.000639 |
GO:0000027 | ribosomal large subunit assembly | 1.2% (2/166) | 6.99 | 9.2e-05 | 0.000767 |
GO:0016462 | pyrophosphatase activity | 5.42% (9/166) | 2.27 | 0.00012 | 0.000989 |
GO:0006457 | protein folding | 3.01% (5/166) | 3.38 | 0.000127 | 0.001032 |
GO:0005737 | cytoplasm | 3.61% (6/166) | 2.95 | 0.000137 | 0.001101 |
GO:0004412 | homoserine dehydrogenase activity | 1.2% (2/166) | 6.67 | 0.000153 | 0.00121 |
GO:0006351 | DNA-templated transcription | 3.01% (5/166) | 3.3 | 0.000165 | 0.00129 |
GO:0005525 | GTP binding | 3.61% (6/166) | 2.87 | 0.000184 | 0.001405 |
GO:0032561 | guanyl ribonucleotide binding | 3.61% (6/166) | 2.87 | 0.000184 | 0.001405 |
GO:0019001 | guanyl nucleotide binding | 3.61% (6/166) | 2.83 | 0.000215 | 0.001618 |
GO:0140098 | catalytic activity, acting on RNA | 4.82% (8/166) | 2.31 | 0.00024 | 0.001785 |
GO:0016272 | prefoldin complex | 1.2% (2/166) | 6.18 | 0.000319 | 0.002347 |
GO:0016043 | cellular component organization | 6.02% (10/166) | 1.93 | 0.000334 | 0.002429 |
GO:0000152 | nuclear ubiquitin ligase complex | 1.2% (2/166) | 5.99 | 0.000424 | 0.002979 |
GO:0004072 | aspartate kinase activity | 1.2% (2/166) | 5.99 | 0.000424 | 0.002979 |
GO:0005680 | anaphase-promoting complex | 1.2% (2/166) | 5.99 | 0.000424 | 0.002979 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4.22% (7/166) | 2.35 | 0.000484 | 0.003361 |
GO:0006839 | mitochondrial transport | 1.81% (3/166) | 4.29 | 0.000493 | 0.003383 |
GO:0006400 | tRNA modification | 1.81% (3/166) | 4.18 | 0.000614 | 0.004121 |
GO:0030163 | protein catabolic process | 1.81% (3/166) | 4.18 | 0.000614 | 0.004121 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.41% (4/166) | 3.37 | 0.000626 | 0.004161 |
GO:0140535 | intracellular protein-containing complex | 3.01% (5/166) | 2.88 | 0.000635 | 0.004177 |
GO:0019202 | amino acid kinase activity | 1.2% (2/166) | 5.53 | 0.000827 | 0.005379 |
GO:0032774 | RNA biosynthetic process | 3.01% (5/166) | 2.71 | 0.001061 | 0.006833 |
GO:0098798 | mitochondrial protein-containing complex | 1.81% (3/166) | 3.9 | 0.001084 | 0.006909 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 1.2% (2/166) | 5.29 | 0.001167 | 0.007068 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.2% (2/166) | 5.29 | 0.001167 | 0.007068 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 1.2% (2/166) | 5.29 | 0.001167 | 0.007068 |
GO:0005730 | nucleolus | 1.2% (2/166) | 5.29 | 0.001167 | 0.007068 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 5.42% (9/166) | 1.82 | 0.001154 | 0.007274 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 1.81% (3/166) | 3.85 | 0.001213 | 0.007277 |
GO:0007346 | regulation of mitotic cell cycle | 1.2% (2/166) | 5.18 | 0.001358 | 0.008067 |
GO:0000049 | tRNA binding | 1.2% (2/166) | 5.08 | 0.001562 | 0.009195 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 1.2% (2/166) | 4.99 | 0.001781 | 0.010191 |
GO:0070585 | protein localization to mitochondrion | 1.2% (2/166) | 4.99 | 0.001781 | 0.010191 |
GO:0072655 | establishment of protein localization to mitochondrion | 1.2% (2/166) | 4.99 | 0.001781 | 0.010191 |
GO:1902494 | catalytic complex | 3.61% (6/166) | 2.24 | 0.001832 | 0.010387 |
GO:0016774 | phosphotransferase activity, carboxyl group as acceptor | 1.2% (2/166) | 4.9 | 0.002013 | 0.010455 |
GO:0043022 | ribosome binding | 1.2% (2/166) | 4.9 | 0.002013 | 0.010455 |
GO:0030515 | snoRNA binding | 1.2% (2/166) | 4.9 | 0.002013 | 0.010455 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.81% (3/166) | 3.6 | 0.001998 | 0.010644 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.81% (3/166) | 3.6 | 0.001998 | 0.010644 |
GO:0043039 | tRNA aminoacylation | 1.81% (3/166) | 3.6 | 0.001998 | 0.010644 |
GO:0043038 | amino acid activation | 1.81% (3/166) | 3.6 | 0.001998 | 0.010644 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.81% (3/166) | 3.6 | 0.001998 | 0.010644 |
GO:0019438 | aromatic compound biosynthetic process | 4.22% (7/166) | 2.01 | 0.001926 | 0.010819 |
GO:0018130 | heterocycle biosynthetic process | 4.22% (7/166) | 2.01 | 0.00195 | 0.010858 |
GO:1990234 | transferase complex | 2.41% (4/166) | 2.89 | 0.002163 | 0.011137 |
GO:0000151 | ubiquitin ligase complex | 1.2% (2/166) | 4.82 | 0.002259 | 0.011443 |
GO:1901987 | regulation of cell cycle phase transition | 1.2% (2/166) | 4.82 | 0.002259 | 0.011443 |
GO:0043021 | ribonucleoprotein complex binding | 1.2% (2/166) | 4.74 | 0.002518 | 0.012351 |
GO:0007005 | mitochondrion organization | 1.2% (2/166) | 4.74 | 0.002518 | 0.012351 |
GO:0005643 | nuclear pore | 1.2% (2/166) | 4.74 | 0.002518 | 0.012351 |
GO:0006289 | nucleotide-excision repair | 1.2% (2/166) | 4.74 | 0.002518 | 0.012351 |
GO:0016787 | hydrolase activity | 13.25% (22/166) | 0.93 | 0.002679 | 0.013037 |
GO:0042254 | ribosome biogenesis | 1.2% (2/166) | 4.67 | 0.002791 | 0.013474 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.22% (7/166) | 1.87 | 0.003295 | 0.015786 |
GO:0018026 | peptidyl-lysine monomethylation | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0035266 | meristem growth | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0090730 | Las1 complex | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0000408 | EKC/KEOPS complex | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0006446 | regulation of translational initiation | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0001056 | RNA polymerase III activity | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0001054 | RNA polymerase I activity | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0004401 | histidinol-phosphatase activity | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0045040 | protein insertion into mitochondrial outer membrane | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0007008 | outer mitochondrial membrane organization | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0005761 | mitochondrial ribosome | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0000313 | organellar ribosome | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0000056 | ribosomal small subunit export from nucleus | 0.6% (1/166) | 7.99 | 0.003935 | 0.016886 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 1.2% (2/166) | 4.4 | 0.004012 | 0.016984 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.2% (2/166) | 4.4 | 0.004012 | 0.016984 |
GO:0005681 | spliceosomal complex | 1.2% (2/166) | 4.35 | 0.00435 | 0.018288 |
GO:0016874 | ligase activity | 2.41% (4/166) | 2.59 | 0.004584 | 0.019014 |
GO:0016887 | ATP hydrolysis activity | 3.01% (5/166) | 2.22 | 0.004574 | 0.019098 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.2% (2/166) | 4.29 | 0.0047 | 0.019111 |
GO:0010498 | proteasomal protein catabolic process | 1.2% (2/166) | 4.29 | 0.0047 | 0.019111 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.2% (2/166) | 4.29 | 0.0047 | 0.019111 |
GO:0003924 | GTPase activity | 2.41% (4/166) | 2.55 | 0.004978 | 0.020106 |
GO:0005096 | GTPase activator activity | 1.2% (2/166) | 4.18 | 0.005439 | 0.021826 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0006433 | prolyl-tRNA aminoacylation | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0004827 | proline-tRNA ligase activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0006435 | threonyl-tRNA aminoacylation | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0009019 | obsolete tRNA (guanine-N1-)-methyltransferase activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0004549 | tRNA-specific ribonuclease activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0007021 | tubulin complex assembly | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0009173 | pyrimidine ribonucleoside monophosphate metabolic process | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0048487 | beta-tubulin binding | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0006222 | UMP biosynthetic process | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0044205 | 'de novo' UMP biosynthetic process | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0009174 | pyrimidine ribonucleoside monophosphate biosynthetic process | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0004588 | orotate phosphoribosyltransferase activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0046049 | UMP metabolic process | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0031307 | obsolete integral component of mitochondrial outer membrane | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0000054 | ribosomal subunit export from nucleus | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0044818 | mitotic G2/M transition checkpoint | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0000055 | ribosomal large subunit export from nucleus | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0016892 | RNA endonuclease activity, producing 3'-phosphomonoesters | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0019774 | proteasome core complex, beta-subunit complex | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0048589 | developmental growth | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0042720 | mitochondrial inner membrane peptidase complex | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0005744 | TIM23 mitochondrial import inner membrane translocase complex | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0000213 | tRNA-intron endonuclease activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0004829 | threonine-tRNA ligase activity | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0033750 | ribosome localization | 0.6% (1/166) | 6.99 | 0.007854 | 0.026095 |
GO:0006520 | amino acid metabolic process | 3.01% (5/166) | 2.09 | 0.006772 | 0.027001 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 1.2% (2/166) | 3.86 | 0.008408 | 0.02764 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.2% (2/166) | 3.86 | 0.008408 | 0.02764 |
GO:1901564 | organonitrogen compound metabolic process | 16.27% (27/166) | 0.69 | 0.009067 | 0.029647 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.2% (2/166) | 3.74 | 0.009858 | 0.032066 |
GO:0009067 | aspartate family amino acid biosynthetic process | 1.2% (2/166) | 3.67 | 0.010882 | 0.035211 |
GO:0006627 | protein processing involved in protein targeting to mitochondrion | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0034982 | mitochondrial protein processing | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0004828 | serine-tRNA ligase activity | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0006434 | seryl-tRNA aminoacylation | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0002949 | tRNA threonylcarbamoyladenosine modification | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0007023 | post-chaperonin tubulin folding pathway | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 0.6% (1/166) | 6.4 | 0.011758 | 0.036151 |
GO:0009066 | aspartate family amino acid metabolic process | 1.2% (2/166) | 3.6 | 0.011951 | 0.036382 |
GO:0008047 | enzyme activator activity | 1.2% (2/166) | 3.6 | 0.011951 | 0.036382 |
GO:0098800 | inner mitochondrial membrane protein complex | 1.2% (2/166) | 3.56 | 0.012502 | 0.037873 |
GO:0004252 | serine-type endopeptidase activity | 1.81% (3/166) | 2.63 | 0.012828 | 0.038671 |
GO:0034248 | regulation of amide metabolic process | 1.2% (2/166) | 3.53 | 0.013064 | 0.039001 |
GO:0006417 | regulation of translation | 1.2% (2/166) | 3.53 | 0.013064 | 0.039001 |
GO:0006913 | nucleocytoplasmic transport | 1.2% (2/166) | 3.47 | 0.01422 | 0.042249 |
GO:0015865 | purine nucleotide transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0030870 | Mre11 complex | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0000077 | DNA damage checkpoint signaling | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0015866 | ADP transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0015867 | ATP transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0015868 | purine ribonucleotide transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0051656 | establishment of organelle localization | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:1990544 | mitochondrial ATP transmembrane transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:1901679 | nucleotide transmembrane transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0140021 | mitochondrial ADP transmembrane transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0072530 | purine-containing compound transmembrane transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0051503 | adenine nucleotide transport | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0042770 | signal transduction in response to DNA damage | 0.6% (1/166) | 5.99 | 0.015647 | 0.042976 |
GO:0010608 | post-transcriptional regulation of gene expression | 1.2% (2/166) | 3.43 | 0.014814 | 0.043803 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.2% (2/166) | 3.37 | 0.016033 | 0.043843 |
GO:0043227 | membrane-bounded organelle | 3.61% (6/166) | 1.57 | 0.016498 | 0.044522 |
GO:0043231 | intracellular membrane-bounded organelle | 3.61% (6/166) | 1.57 | 0.016498 | 0.044522 |
GO:0016779 | nucleotidyltransferase activity | 1.81% (3/166) | 2.5 | 0.016429 | 0.044728 |
GO:0051169 | nuclear transport | 1.2% (2/166) | 3.4 | 0.015418 | 0.045373 |
GO:0019752 | carboxylic acid metabolic process | 3.61% (6/166) | 1.56 | 0.01707 | 0.045867 |
GO:0043436 | oxoacid metabolic process | 3.61% (6/166) | 1.55 | 0.017509 | 0.046841 |
GO:0006082 | organic acid metabolic process | 3.61% (6/166) | 1.55 | 0.017656 | 0.047033 |
GO:0031503 | protein-containing complex localization | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0030150 | protein import into mitochondrial matrix | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0051640 | organelle localization | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0040007 | growth | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0098799 | outer mitochondrial membrane protein complex | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:1902555 | endoribonuclease complex | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0005742 | mitochondrial outer membrane translocase complex | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0005666 | RNA polymerase III complex | 0.6% (1/166) | 5.67 | 0.01952 | 0.048447 |
GO:0009057 | macromolecule catabolic process | 2.41% (4/166) | 2.0 | 0.018344 | 0.048448 |
GO:0044281 | small molecule metabolic process | 4.82% (8/166) | 1.28 | 0.018333 | 0.048626 |
GO:0005634 | nucleus | 3.01% (5/166) | 1.72 | 0.01869 | 0.04915 |